Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells

Carcinogenesis

Volumn 34, Issue 7, 2013, Pages 1644-1652

  You, Xiaona ^a   Liu, Fabao ^a   Zhang, Tao ^a   Li, Yinghui ^a   Ye, Lihong ^a   Zhang, Xiaodong ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 1; ARACHIDONATE 5 LIPOXYGENASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; HEPATITIS B VIRUS X PROTEIN; RAB18 PROTEIN; RAS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIPOGENESIS; LIVER CARCINOGENESIS; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; UNTRANSLATED REGION; UPREGULATION;

ANIMALS; BINDING SITES; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HEK293 CELLS; HEP G2 CELLS; HEPATITIS B VIRUS; HUMANS; LIPOGENESIS; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; MICE, TRANSGENIC; MICRORNAS; PROMOTER REGIONS, GENETIC; RAB GTP-BINDING PROTEINS; TRANS-ACTIVATORS; UP-REGULATION;

EID: 84880282714     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt089     Document Type: Article

References (44)

1. Michielsen, P. et al. (2011) Viral hepatitis B and hepatocellular carcinoma. Acta Gastroenterol. Belg., 74, 4-8.
2. Gurtsevitch, V.E. (2008) Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis. Biochemistry Mosc., 73, 504-513.
3. Ng, S.A. et al. (2011) Hepatitis B virus X gene and hepatocarcinogenesis. J. Gastroenterol., 46, 974-990.
4. Kew, M.C. (2011) Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma. J. Gastroenterol. Hepatol., 26 suppl. 1, 144-152.
5. Zhang, X. et al. (2006) Effects of hepatitis B virus X protein on the development of liver cancer. J. Lab. Clin. Med., 147, 58-66.
6. Diao, J. et al. (2001) X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway. J. Biol. Chem., 276, 8328-8340.
7. Shan, C. et al. (2010) Hepatitis B virus X protein promotes liver cell proliferation via a positive cascade loop involving arachidonic acid metabolism and p-ERK1/2. Cell Res., 20, 563-575.
8. Tang, H. et al. (2006) Molecular functions and biological roles of hepatitis B virus x protein. Cancer Sci., 97, 977-983.
9. Na, T.Y. et al. (2009) Liver X receptor mediates hepatitis B virus X proteininduced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma. Hepatology, 49, 1122-1131.
10. Tang, H. et al. (2009) Hepatitis B virus X protein sensitizes cells to starvation-induced autophagy via up-regulation of beclin 1 expression. Hepatology, 49, 60-71.
11. Du, Y. et al. (2012) Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J. Biol. Chem., 287, 26302-26311.
12. Wang, Q. et al. (2010) A mutant of hepatitis B virus X protein (HBxDelta127) promotes cell growth through a positive feedback loop involving 5-lipoxygenase and fatty acid synthase. Neoplasia, 12, 103-115.
13. Zhang, T. et al. (2012) Hepatitis B virus X protein (HBx) modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells. Hepatology, 56, 2051-2059.
14. Chia, W.J. et al. (2009) Emerging roles for Rab family GTPases in human cancer. Biochim. Biophys. Acta, 1795, 110-116.
15. Yang, P.S. et al. (2011) Rab5A is associated with axillary lymph node metastasis in breast cancer patients. Cancer Sci., 102, 2172-2178.
16. Tang, B.L. et al. (2009) Rabs and cancer cell motility. Cell Motil. Cytoskeleton, 66, 365-370.
17. Cheng, K.W. et al. (2005) Emerging role of RAB GTPases in cancer and human disease. Cancer Res., 65, 2516-2519.
18. Yin, Y.X. et al. (2012) Increased expression of Rab25 in breast cancer correlates with lymphatic metastasis. Tumour Biol., 33, 1581-1587.
19. Cheng, K.W. et al. (2004) The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat. Med., 10, 1251-1256.
20. Fukui, K. et al. (2007) Expression of Rab5a in hepatocellular carcinoma: possible involvement in epidermal growth factor signaling. Hepatol. Res., 37, 957-965.
21. Zhao, Z. et al. (2010) Rab5a overexpression promoting ovarian cancer cell proliferation may be associated with APPL1-related epidermal growth factor signaling pathway. Cancer Sci., 101, 1454-1462.
22. Pulido, M.R. et al. (2011) Rab18 dynamics in adipocytes in relation to lipogenesis, lipolysis and obesity. PLoS ONE, 6, e22931.
23. Behrends, U. et al. (2003) Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries. Int. J. Cancer, 106, 244-251.
24. Yu, Z. et al. (2012) miRNAs regulate stem cell self-renewal and differentiation. Front. Genet., 3, 191.
25. Saito, Y. et al. (2012) MicroRNAs in cancers and neurodegenerative disorders. Front. Genet., 3, 194.
26. Zhang, S. et al. (2012) MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK). Oncogene, 31,3607-3620.
27. Hu, N. et al. (2011) miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8. J. Biol. Chem., 286, 13714-13722.
28. Zhang, X. et al. (2005) Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells. J. Lab. Clin. Med., 145, 98-104.
29. Zhang, X. et al. (2005) Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues. J. Med. Virol., 77, 374-381.
30. Kong, G. et al. (2011) Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS ONE, 6, e19518.
31. Carmona, S. et al. (2006) Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs. Mol. Ther., 13, 411-421.
32. Kwak, Y.T. et al. (2011) Cells lacking IKKa show nuclear cyclin D1 overexpression and a neoplastic phenotype: role of IKKa as a tumor suppressor. Mol. Cancer Res., 9, 341-349.
33. Wang, Y. et al. (2004) HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice. Hepatology, 39, 318-324.
34. Servillo, G. et al. (2002) Coupling cAMP signaling to transcription in the liver: pivotal role of CREB and CREM. Exp. Cell Res., 275, 143-154.
35. Abramovitch, R. et al. (2004) A pivotal role of cyclic AMP-responsive element binding protein in tumor progression. Cancer Res., 64, 1338-1346.
36. Liu, Z. et al. (2012) Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells. Biochem. J., 442, 273-282.
37. Cougot, D. et al. (2007) The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription. J. Biol. Chem., 282, 4277-4287.
38. Tanaka, Y. et al. (2006) The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1. Oncogene, 25, 633-642.
39. Boileau, C. et al. (2005) The regulation of human MMP-13 by licofelone, an inhibitor of cyclo-oxygenases and 5-lipoxygenase, in human osteoarthritic chondrocytes is mediated by the inhibition of the p38 MAP kinase signalling pathway. Ann. Rheum. Dis., 64, 891-898.
40. Jain, S. et al. (2008) Prostaglandin E2 regulates tumor angiogenesis in prostate cancer. Cancer Res., 68, 7750-7759.
41. Kim, T. et al. (2011) p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J. Exp. Med., 208, 875-883.
42. Dewantoro, O. et al. (2006) Hepatocarcinogenesis in viral Hepatitis B infection: the role of HBx and p53. Acta Med. Indones., 38, 154-159.
43. Bracken, C.P. et al. (2008) A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res., 68, 7846-7854.
44. Dohadwala, M. et al. (2006) Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. Cancer Res., 66, 5338-5345.